184 related articles for article (PubMed ID: 38149011)
1. Isolation and characterization of three novel lytic phages against K54 serotype carbapenem-resistant hypervirulent
Fang C; Dai X; Xiang L; Qiu Y; Yin M; Fu Y; Li Y; Zhang L
Front Cell Infect Microbiol; 2023; 13():1265011. PubMed ID: 38149011
[TBL] [Abstract][Full Text] [Related]
2. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant
Bai J; Zhang F; Liang S; Chen Q; Wang W; Wang Y; Martín-Rodríguez AJ; Sjöling Å; Hu R; Zhou Y
Front Cell Infect Microbiol; 2022; 12():897531. PubMed ID: 35865823
[TBL] [Abstract][Full Text] [Related]
4. Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11.
Liu S; Xu H; Cao R; Yang Z; Li X
J Glob Antimicrob Resist; 2024 Jun; 37():179-184. PubMed ID: 38561142
[TBL] [Abstract][Full Text] [Related]
5. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
Fang Q; Zong Z
mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
[TBL] [Abstract][Full Text] [Related]
7. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates.
Horváth M; Kovács T; Koderivalappil S; Ábrahám H; Rákhely G; Schneider G
Sci Rep; 2020 Apr; 10(1):5891. PubMed ID: 32246126
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Carbapenem-Resistant Hypervirulent
Hu D; Chen W; Zhang Q; Li M; Yang Z; Wang Y; Huang Y; Li G; Tian D; Fu P; Wang W; Ren P; Mu Q; Yu L; Jiang X
Front Cell Infect Microbiol; 2022; 12():882210. PubMed ID: 35719357
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and Genomic Comparison of
Pacios O; Fernández-García L; Bleriot I; Blasco L; Ambroa A; López M; Ortiz-Cartagena C; Cuenca FF; Oteo-Iglesias J; Pascual Á; Martínez-Martínez L; Domingo-Calap P; Tomás M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062209
[No Abstract] [Full Text] [Related]
10. Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae.
Feng Y; Fang Q; Luo H; Li J; Yin X; Zong Z
Int J Antimicrob Agents; 2024 Feb; 63(2):107088. PubMed ID: 38218324
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and Genotypic Characterization of a Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae ST17-KL38 Clinical Isolate Harboring the Carbapenemase IMP-4.
He J; Du X; Zeng X; Moran RA; van Schaik W; Zou Q; Yu Y; Zhang J; Hua X
Microbiol Spectr; 2022 Apr; 10(2):e0213421. PubMed ID: 35225687
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent
Xie M; Ye L; Chen K; Xu Q; Yang C; Chen X; Chan EW; Li F; Chen S
Emerg Microbes Infect; 2024 Dec; 13(1):2306957. PubMed ID: 38240375
[TBL] [Abstract][Full Text] [Related]
13. Interruption of Capsular Polysaccharide Biosynthesis Gene
Yin X; Fang Q; Zong Z
mSphere; 2022 Dec; 7(6):e0051822. PubMed ID: 36377881
[TBL] [Abstract][Full Text] [Related]
14. Detection of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan.
Huang Y; Li J; Wang Q; Tang K; Cai X; Li C
J Hosp Infect; 2023 Jan; 131():70-80. PubMed ID: 36183928
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hypervirulent and carbapenem-resistant
Tian D; Liu X; Chen W; Zhou Y; Hu D; Wang W; Wu J; Mu Q; Jiang X
Emerg Microbes Infect; 2022 Dec; 11(1):1936-1949. PubMed ID: 35844192
[TBL] [Abstract][Full Text] [Related]
16. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital.
Ouyang P; Jiang B; Peng N; Wang J; Cai L; Wu Y; Ye J; Chen Y; Yuan H; Tan C; Tan L; Xie L
J Clin Lab Anal; 2022 Jun; 36(6):e24476. PubMed ID: 35522153
[TBL] [Abstract][Full Text] [Related]
18. A novel phage putative depolymerase, Depo16, has specific activity against K1 capsular-type
Zhao R; Jiang S; Ren S; Yang L; Han W; Guo Z; Gu J
Appl Environ Microbiol; 2024 Apr; 90(4):e0119723. PubMed ID: 38551353
[No Abstract] [Full Text] [Related]
19. LysZX4-NCA, a new endolysin with broad-spectrum antibacterial activity for topical treatment.
Li P; Shen M; Ma W; Zhou X; Shen J
Virus Res; 2024 Feb; 340():199296. PubMed ID: 38065302
[TBL] [Abstract][Full Text] [Related]
20.
Zhao J; Pu D; Li Z; Liu X; Zhang Y; Wu Y; Zhang F; Li C; Zhuo X; Lu B; Cao B
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0073523. PubMed ID: 38014944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
